Cargando…
Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases
Chimeric antigen receptor T (CAR-T) cells are T cells engineered to express specific synthetic antigen receptors that can recognize antigens expressed by tumor cells, which after the binding of these antigens to the receptors are eliminated, and have been adopted to treat several kinds of malignanci...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012264/ https://www.ncbi.nlm.nih.gov/pubmed/32083141 http://dx.doi.org/10.1155/2019/5727516 |